Abstract:OBJECTIVE:To explore the circadian blood pressure (BP) profile and its influencing factors in essential hypertensive patients after treatment. METHODS:Cross-sectional surveillance was carried out in essential hypertensive subjects after treatment whose clinic blood pressure had been under control as 140/90 mm Hg (1 mm Hg = 0.133 kPa) for at least one month. All patients underwent a twenty-four-hour ambulatory blood pressure monitoring device (spacelabs 90207). The nocturnal fall of blood pressure (BP) was calculated from (daytime mean BP-night-time mean BP)/daytime BP, while 'daytime' values were recorded between 6 h and 22 h and 'night-time' values between 22 h and 6 h. Non-dippers were defined as those whose nocturnal decrease in mean systolic BP and/or mean diastolic BP was < 10% of the daytime BP. Binary logistic regression analysis was used to evaluate the correlation between circadian blood pressure profile and factors as gender, age, height, body mass index (BMI), family history of premature cardiovascular disease, women under age 65 or men under age 55, smoking habits, grade of hypertension, and strategy of antihypertensive drugs. RESULTS:208 treated essential hypertensive patients were enrolled in the study. 79 individuals were dippers and 129 were non-dippers. Data from logistic regression analysis showed that four factors as age, premature family history of cardiovascular disease, overweight or obesity, and strategy of antihypertensive drugs were significantly influencing the circadian blood pressure profile in treated hypertensive patients. The incidence of non-dippers in patients of 70 years of age or older and those between 60 and 69 were 3.3 and 2.3 times of those with less than 60 (P = 0.009 and 0.031, respectively). The prevalence of non-dippers in patients with a premature family history of cardiovascular disease was 3.7 times greater than those in subjects without a premature history of cardiovascular disease (P = 0.029). Similarly, the incidence of non-dippers in patients of overweight (24 = BMI < 28) and obesity (BMI >/= 28) were 3.0 and 4.8 times of those in subjects of normal weight (P = 0.003 and 0.009, respectively). Compared with patients treated with long-acting calcium channel blockers (CCBs), patients treated with angiotensin-converting enzyme (ACE) inhibitors or angiotensin II receptor blockers (ARBs) alone had less prevalence of nondippers (OR = 0.139, P = 0.010). Patients treated with joint antihypertensive scheme including ACE inhibitors or ARBs(but not including diuretics) had the tendency of lower incidence of abnormal circadian blood pressure rhythm (OR = 0.453, P = 0.118). Patients treated with joint antihypertensive scheme including diuretics (not including ACE inhibitors or ARBs) and with joint antihypertensive strategy including diuretics and ACE inhibitors or ARBs had lower incidence of nondippers (OR = 0.378 and 0.273, respectively; P = 0.030 and 0.011, respectively). CONCLUSIONS:Approximately 2/3 treated essential hypertensive patients had a non-dipper blood pressure profile. Age, premature family history of cardiovascular disease, overweight/obesity, and antihypertensive drugs strategy were correlated with circadian blood pressure profile. Compared with long-acting CCBs, diuretics, ACE inhibitors or ARBs might be helpful in keeping the circadian blood pressure rhythm at normal range.

Seasonal Variation in Ambulatory Blood Pressure Control in Patients on Clinic Blood Pressure-Guided Antihypertensive Treatment.

Seasonal Variation in the Effect of Antihypertensive Treatment with the Irbesartan/hydrochlorothiazide Combination

The Seasonal Variation of Blood Pressure in Hypertensive Patents Treated with Combination Therapy in Chief Trial

Long-term amlodipine-based combination therapy attenuates seasonal variation of blood pressure in hypertensive patients

Profile on Circadian Blood Pressure and the Influencing Factors in Essential Hypertensive Patients after Treatment

Seasonal variation in blood pressure control across US health systems

The Effects Between Single Long-Acting and Combination of Short-Acting Antihypertensive Drugs Treatment on Visit-to-visit Systolic Blood Pressure Variability

Seasonal variation in blood pressure: Evidence, consensus and recommendations for clinical practice. Consensus statement by the European Society of Hypertension Working Group on Blood Pressure Monitoring and Cardiovascular Variability.

Season and Outdoor Temperature in Relation to Detection and Control of Hypertension in a Large Rural Chinese Population.

SEASONALITY IN NIGHT-TIME BLOOD PRESSURE AND ITS ASSOCIATIONS WITH TARGET ORGAN DAMAGE

Blood pressure measurement under standardized indoor condition may mask seasonal blood pressure variation in men with mildly elevated blood pressure

[Seasonal Variation of Blood Pressure and Related Factors in Chinese Adults: a Survey of over 50 000 People in Suzhou, China].

Seasonal Variation in Blood Pressure of Patients on Continuous Ambulatory Peritoneal Dialysis.

Seasonal Changes in Blood Pressure in Chronic Kidney Disease Patients.

Seasonal Variation in Blood Pressure and Its Relationship with Outdoor Temperature in 10 Diverse Regions of China: the China Kadoorie Biobank

SEASONAL VARIATION IN BLOOD PRESSURE AMONG CHINESE ADULTS: THE KADOORIE BIOBANK STUDY OF 0.5 MILLION PEOPLE IN CHINA

Twenty-four-hour Ambulatory Blood Pressure Changes in Older Patients with Essential Hypertension Receiving Monotherapy or Dual Combination Antihypertensive Drug Therapy.

The control rate of hypertension across months of year and hours of day in a large real-world database

Clinical Blood Pressure Responses to Daily Ambient Temperature Exposure in China: an Analysis Based on a Representative Nationwide Population

Outdoor temperature and temperature maintenance associated with blood pressure in 438,811 Chinese adults

Effect of the seasonally adjusted antihypertensive regimen on cardiovascular events in patients with essential hypertension